MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00467-026-07491-4

Медицинская библиотека · Pediatric nephrology (Berlin, Germany) · 2026

Patterns of kidney involvement after corticosteroid treatment for extrarenal symptoms in pediatric IgA vasculitis (Henoch-Schönlein Purpura): phenotypes and outcomes.

Kim Da Hyun, Lee Joo Hoon, Park Jun Sung, Lee Jeong-Yong, Choi Seung Jun, Lee Jong Seung, Jung Jiwon

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Corticosteroids are frequently used for extrarenal manifestations of Immunoglobulin A vasculitis (IgAV); however, their impact on the development and phenotypic pattern of kidney involvement remains unclear. We evaluated whether early steroid administration influences the incidence, timing, and phenotypic expression of kidney involvement.

METHODS

We retrospectively analyzed pediatric IgAV patients at a tertiary center (2019-2025). Patients were stratified by whether systemic corticosteroids were administered within 4 weeks of extrarenal symptom onset. Outcomes included the incidence, timing, and phenotypic severity of kidney involvement and urinary normalization rates.

RESULTS

Among 211 patients (median follow-up duration: 2.43 [IQR 0.90-8.33] months), kidney involvement occurred in 20/92 (21.7%) of the steroid-treated and 14/119 (11.8%) of the non-steroid group without significant difference (p = 0.054, odds ratio 2.083, 95% CI 0.988-4.932). The steroid group exhibited significantly higher baseline disease severity, including gastrointestinal (73.9%, 68/92) and joint (67.4%, 62/92) symptoms and higher inflammatory markers, with no significant between-group difference in the median time to kidney involvement (1.03 vs. 0.72 months). However, steroid-treated patients were significantly more likely to present with microscopic hematuria and milder proteinuria (50.0% vs. 21.4%, p = 0.021) among kidney phenotypes. Notably, in the moderate proteinuria subgroup, none of the steroid-treated patients achieved full urinary normalization, compared with 75% of the non-steroid group.

CONCLUSIONS

Early corticosteroid treatment for extrarenal IgAV symptoms does not prevent, delay, or mask later kidney involvement. While it may shift the phenotypic expression toward milder hematuria-proteinuria patterns, it may not improve long-term urinary resolution in cases with more severe proteinuria.

Для цитирования: Kim Da Hyun, Lee Joo Hoon, Park Jun Sung, Lee Jeong-Yong, Choi Seung Jun, Lee Jong Seung, Jung Jiwon. Patterns of kidney involvement after corticosteroid treatment for extrarenal symptoms in pediatric IgA vasculitis (Henoch-Schönlein Purpura): phenotypes and outcomes.. Pediatric nephrology (Berlin, Germany). 2026. DOI: 10.1007/s00467-026-07491-4.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.